However, accumulating evidence has shown that COUP-TFII expression is elevated under pathological conditions and COUP-TFII overexpression promotes progression of a spectrum of diseases, including cancer, heart failure and muscular dystrophy [[17], [18], [19], [20]]. This evidence concerns the gene NR2F2 and muscular dystrophy.